Northwest Biotherapeutics (NWBO) Treasury Shares (2012 - 2026)

Northwest Biotherapeutics' Treasury Shares history runs 2 years deep, the most recent figure standing at $12000.0 for Q1 2026.

• In Q1 2026, Treasury Shares rose 1227.43% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $12.0 million (up 1227.43% YoY), while the FY2025 annual figure was $12.0 million, up 1133.3% from the prior year.
• Treasury Shares for Q1 2026 stood at $12000.0, roughly flat from $12000.0 in the prior quarter.
• The five-year high for Treasury Shares was $12.0 million in Q4 2025, with the low at $818000.0 in Q3 2025.
• The 4-year median for Treasury Shares is $904000.0 (2025), against an average of $4.1 million.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares jumped 1133.3% in 2025, then surged 1227.43% in 2026.
• Northwest Biotherapeutics' Treasury Shares stood at $885000.0 in 2022, then increased by 9.94% to $973000.0 in 2024, then surged by 1133.3% to $12.0 million in 2025, then changed by 0.0% to $12.0 million in 2026.
• Business Quant data shows NWBO's Treasury Shares at $12.0 million in Q1 2026, $12.0 million in Q4 2025, and $818000.0 in Q3 2025.